The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fingolimod Pharmathen 0.5 mg hard capsules

Pharmathen S.A.PA1368/019/001

Main Information

Trade NameFingolimod Pharmathen 0.5 mg hard capsules
Active SubstancesFingolimod
Dosage FormCapsule, hard
Licence HolderPharmathen S.A.
Licence NumberPA1368/019/001

Group Information

ATC CodeL04AA27 fingolimod


License statusAuthorised
Licence Issued09/04/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back